| Title | Intervention |
NCT ID |
Sponsor | Status |
|---|---|---|---|---|
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) | anastrozole, questionnaire administration, laboratory biomarker analysis, pharmacogenomic studies | NCT01824836 | Eastern Cooperative Oncology Group | Active, not recruiting |
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In... | metformin hydrochloride, placebo | NCT01905046 | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer | Adaptation of IMCP for Chinese Immigrant Cancer Patients, In-depth Patient Interviews, Individual Meaning-Centered Psychotherapy for Chinese (IMCP-Ch) (For Phase 3) | NCT02112188 | Memorial Sloan Kettering Cancer Center | Recruiting |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline | NCT02134925 | National Cancer Institute (NCI) | Active, not recruiting |
| Iloprost in Preventing Lung Cancer in Former Smokers | Iloprost, Quality-of-Life Assessment, Questionnaire Administration, Placebo Administration | NCT02237183 | National Cancer Institute (NCI) | Active, not recruiting |
| VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue | Fish oil and vitamin D placebo, Vitamin D and fish oil, Vitamin D and fish oil placebo, Vitamin D placebo and fish oil placebo | NCT02239874 | Brigham and Women's Hospital | Active, not recruiting |
| MRI Based Active Selection for Treatment Trial | MRI-Guided Biopsy, Multi-Parametric MRI | NCT02242773 | University of Miami | Active, not recruiting |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver | Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment | NCT02273362 | National Cancer Institute (NCI) | Active, not recruiting |
| Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention | omega 3 fatty acids | NCT02295059 | City of Hope Medical Center | Active, not recruiting |
| Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... | Endocrine therapy interruption | NCT02308085 | ETOP IBCSG Partners Foundation | Active, not recruiting |
Why I Joined a Clinical Trial
After seeing what my own family went through with cancer, I’m blessed to have the opportunity to make other people’s lives better. I’m a lifelong blood donor too, so I’m always looking for ways to give of myself to help others.